A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Metahexamide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Metahexamide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Guar gum
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Guar gum.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Carbutamide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Carbutamide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Remogliflozin etabonate
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Remogliflozin etabonate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Balaglitazone
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Balaglitazone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Sotagliflozin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Sotagliflozin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Evogliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Evogliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Anagliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Anagliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Gemigliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Gemigliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Carmegliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Carmegliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Omarigliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Omarigliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Teneligliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Teneligliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
2,4-thiazolidinedione
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with 2,4-thiazolidinedione.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Tofogliflozin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Tofogliflozin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Allicin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Allicin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Dutogliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Dutogliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Ipragliflozin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Ipragliflozin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Insulin tregopil
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin tregopil.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Insulin peglispro
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin peglispro.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Insulin degludec
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin degludec.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3